Victrex (VCT)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 18.2 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 5.17 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 30th Sep | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | |||||||||
| Operating Profit | £m | |||||||||
| Net Profit | £m | |||||||||
| EPS Reported | p | |||||||||
| EPS Normalised | p | |||||||||
| EPS Growth | % | |||||||||
| PE Ratio | x | |||||||||
| PEG | x | |||||||||
| Profitability | ||||||||||
| Operating Margin | % | |||||||||
| ROA | % | |||||||||
| ROCE | % | |||||||||
| ROE | % | |||||||||
| Cashflow | ||||||||||
| Op. Cashflow ps | p | |||||||||
| Capex ps | p | |||||||||
| Free Cashflow ps | p | |||||||||
| Last ex-div: 6th Feb, paid: 22nd Feb more... Dividends | ||||||||||
| Dividend ps | p | |||||||||
| Dividend Growth | % | |||||||||
| Dividend Yield | % | |||||||||
| Dividend Cover | x | |||||||||
| Balance Sheet | ||||||||||
| Cash etc | £m | |||||||||
| Working Capital | £m | |||||||||
| Net Fixed Assets | £m | |||||||||
| Net Debt | £m | |||||||||
| Book Value | £m | |||||||||
| Average Shares | m | |||||||||
| Book Value ps | p | +13.3% | ||||||||
FINANCIAL BRIEF: For the fiscal year ended 30 September 2012, Victrex plc revenues increased 2% to L219.8M. Net income increased 1% to L71.9M. Revenues reflect VICTREX PEEK segment increase of 2% to L169.3M, Invibio segment increase of 2% to L50.5M, Americas segment increase of 10% to L81.2M, Asia-Pacific segment increase of 5% to L41.7M, United Kingdom segment increase of 11% to L5.9M. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 30th Sep '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 1 | 3 | 5 | 2 | 1 |
Victrex plc is a holding company. The Company is a manufacturer of high-performance polyaryletherketones, including VICTREX PEEK polymer. Its business is organized as two business units: Victrex Polymer Solutions (VPS) and Invibio Biomaterial Solutions (Invibio). VPS provides a range of products, together with technical and marketing support to its customers and end users to help them deliver new, cost effective solutions in its markets of industrial, transport and electronics. Invibio provides versatile PEEK-based polymers to address the needs of the long-term implantable medical device market. Its materials are used across a number of applications, including spinal fusion and motion preservation, arthroscopy, joint replacement, trauma, cardio-neuro and cranio-maxillo facial implants. The Company’s subsidiaries include Victrex Manufacturing Limited, invibio Limited, Victrex Japan, Inc. Victrex USA, Inc. and Invibio USA, Inc.
Directors: David Hummel (CEO) , A. Steve Barrow (Fin. Dir.) , Suzana Koncarevic (Counsel) , Tim Cooper (Exec. Dir.) ,
No. of Employees: 607 No. of Shareholders: n/a
| Last Annual | September 30th, 2012 |
| Last Interim | September 30th, 2012 |
| Shares in Issue | 84,591,659 |
| Free Float | 79.1m (93.5%) |
| Sector | Basic Materials |
| Industry | Chemicals |
| Index | FTSE 350 Act , FTSE Lower Yield , FTSE 250 Mid , FT350 Chemicals , |
| Exchange |
London Stock Exchange (Full) |
| Eligible for | an ISA? a SIPP? |
| Address | Victrex Technology Centre,Hillhouse International, Thornton Cleveleys, THORNTON CLEVELEYS, FY5 4QD, United Kingdom |
| Web | http://www.victrex.com/en |
| Phone | +44 1253 897700 |
| Contact | Michael Peacock (Finance Director) |
| Auditors | KPMG Audit PLC |
| Fri 1:39pm | Director/PDMR Shareholding |
| 24th Apr | Holding(s) in Company |
| 22nd Apr | Holding(s) in Company |
| 22nd Apr | Holding(s) in Company |
| 17th Apr | Director/PDMR Shareholding |
| 16th Apr | Holding(s) in Company |
Recent ↓
